CloudFrame today announced it has been named a Rising Star in ISG's 2026 Provider Len (R) Mainframe Services and Solutions study. A designation awarded to vendors demonstrating strong portfolio depth ...

Mojang has recently released the 1.21.9 update for Minecraft Java Edition. This new Copper Age update has brought in many major changes and features to the game, making players have a whole new ...

The Texas Longhorns are no strangers to making or rewriting history, as the Longhorns softball program rewrites another chapter of its history on Friday night. The Longhorns headed into a two-game ...

CHICAGO (WLS) -- Cook County it will continue funding the medical debt forgiveness program next year, once funds run out, Board of Commissioners President Tony Preckwinkle announced Tuesday. The ...

James Ratcliff joined GameRant in 2022 as a Gaming News Writer. In 2023, James was offered a chance to become an occasional feature writer for different games and then a Senior Author in 2025. He is a ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.